trial

Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder

NCTId NCT03848234
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 209 (actual)
Sponsored by Tangent Data Srl
Primary completion 2016-07-29
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
209 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2015-12-04
Primary completion
2016-07-29
Eligibility
FEMALE · 18 Years · 45 Years

Interventions & indications

Drugs
Estradiol

Sponsors

Tangent Data SrlLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
Paull G Radu, M.D.Study Director

Sites

1 total
Codru, Moldova

Linked catalysts

1
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schi — primary completion2016-07-29

Facts & assertions

4 sourced
Enrollment
209
Phase
PHASE3
Primary Completion Date
2016-07-29
Status
COMPLETED
relationships
The graph out of here
drug
Estradiol
drug
lead_sponsor
Tangent Data Srl
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophreniform Disorders
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Paull G Radu, M.D.
person